Clinical Trials
6 trialsNCT02592317 2026-05-08
A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer
Aragon Pharmaceuticals, Inc.
Phase 1 Active not recruiting
NCT05098327 2023-08-15
Pioglitazone and Insulin Resistance in ADT
State University of New York at Buffalo
Phase 3 Withdrawn
NCT04995978 2023-06-23
Insulin Resistance and Androgen Deprivation Therapy
St. Louis University
Phase 2 Withdrawn
NCT04658849 2023-05-15
Insulin Resistance Following ADT for Prostate CA
St. Louis University
Phase EARLY_PHASE1 Withdrawn
NCT01911728 2017-06-26
Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates
Astellas Pharma Inc
Phase 1 Completed
NCT00427999 2016-11-21
INV342
Novartis
Phase 2 Completed